Clinical Trials

Study Title:
A PHASE 1B/2 STUDY OF AVB S6 500 IN COMBINATION WITH CABOZANTINIB, AVB S6 500 IN COMBINATION WITH CABOZANTINIB AND NIVOLUMAB, AND AVB S6 500 MONOTHERAPY IN PATIENTS WITH ADVANCED OR METASTATIC CLEAR CELL RENAL CELL CARCINOMA

For more information about the trial above please contact the study team:

Principal Investigator, Theodore Gourdin, at gourdith@musc.edu.

Study Coordinator, Carly Fecio, at fecio@musc.edu.

Trial opened at the following institutions: Medical University of South Carolina